Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
AIMS Public Health|May 31, 2022
Inpatient violence in a psychiatric hospital in the middle of the pandemic: clinical and community health aspectsVal Bellman, David Thai, Anisha Chinthalapally, et al.Psychiatry Journal|May 2, 2022
Malingering of Psychotic Symptoms in Psychiatric Settings: Theoretical Aspects and Clinical ConsiderationsVal Bellman, Anisha Chinthalapally, Ethan Johnston, et al.Vaccine|May 18, 2010
The potential global market size and public health value of an HIV-1 vaccine in a complex global marketCarol A Marzetta, Stephen S Lee, Sandra J Wrobel, et al.World Journal of Oncology|November 22, 2021
Challenges in Treating Cancer Patients With Unstable Psychiatric DisorderVal Bellman, Nina Russell, Kartik Depala, et al.Plos One|November 5, 2010
Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054)Laurence Peiperl, Cecilia Morgan, Zoe Moodie, et al.The Journal of Infectious Diseases|October 13, 2004
Correlation between interferon- gamma secretion and cytotoxicity, in virus-specific memory T cellsHelen Horton, Nina Russell, Erin Moore, et al.AIDS Research and Human Retroviruses|May 27, 2014
The immune space: a concept and template for rationalizing vaccine developmentAmapola Manrique, Elizabeth Adams, Dan H Barouch, et al.The Journal of Infectious Diseases|September 24, 2011
Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjectsLindsey R Baden, William A Blattner, Cecilia Morgan, et al.Pageof 1